New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

RECURSOS

/

ENCUENTRA UN ESPECIALISTA

/

CONTACTO

Ana Josa

Coordinator, Patient Engagement

Ana Josa serves as NephCure’s Patient Engagement Coordinator. She brings a strong background in community health, patient-centered programming, and outreach. In her role, Ana works closely with patients, caregivers, and community partners to foster meaningful connections, enhance engagement, and ensure patients feel informed, supported, and empowered throughout their healthcare journey. Ana is passionate about creating accessible, culturally responsive resources that meet patients where they are.

Ana holds a Bachelor of Science in Public Health from the University of Houston and is a Certified Community Health Worker. Prior to joining NephCure, Ana worked as a Health Program Coordinator with a local non-profit and as a Community Health Worker with Harris Health, supporting diverse communities through care coordination, health education, and resource navigation.
A Houston native, Ana, grew up in Houston, Texas and currently resides in the city. Outside of work, she enjoys spending time with her two dogs, watching movies, and staying active by playing tennis.

Houston, TX

Noticias relacionadas

NOTICIAS

NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan

NOTICIAS

NephCure Celebrates C3G Awareness Day on September 25, 2026

NOTICIAS

NephCure Specialist of the Month: Dr. Rupali Avasare

NOTICIAS

Making History on Capitol Hill: Record Advocates Unite for NephCure’s Largest Hill Day Ever

Regístrese para recibir las últimas actualizaciones de NephCure.

INSCRIBIRSE
Este campo es para fines de validación y no debe modificarse.